Ironwood Pharmaceuticals - Top 20 VC deals of 2008

Ironwood Pharmaceuticals, Fiercebiotech's top venture capital deals of 2008Company: Ironwood Pharmaceuticals
Based: Cambridge, MA
Amount: $50M

Investors: Fidelity Biosciences, Venrock Associates, Polaris Venture Partners, Morgan Stanley Private Equity

Scoop: Ironwood secured $50 million in private equity financing in October. The company is using the funds to support its ongoing Phase III  program  for linaclotide, a treatment for irritable bowel syndrome with constipation and chronic constipation. Ironwood is also investing in its pipeline of internally discovered drug candidates, and expanding its commercial capabilities.

Ironwood Pharmaceuticals - Top 20 VC deals of 2008
Read more on

Suggested Articles

Researchers are studying the retrovirus KoRV-A, which is spreading among koalas, to gain new insights into how DNA evolves.

Shionogi and Hsiri Therapeutics first joined forces last year in a licensing and R&D deal focused on tuberculosis and non-tuberculous lung infections.

The efficacy results suggest the experimental oral therapy, abrocitinib, has a shot at challenging the blockbuster biologic incumbent.